PD-L1 Expression in Colorectal Cancer and Its Relation to Microsatellite Instability and Cytotoxic Tumor-Infiltrating Lymphocytes

Prognostic Value of Programed Cell Death-1 Ligand Expression in Colorectal Cancer and Its Correlation with Cytotoxic Tumor-Infiltrating Lymphocytes

Programmed death protein 1 (PD1) mRNA expression as a screening and diagnostic tool in colon cancer

FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy

The Expression of Immune Checkpoint Inhibitors PDL-1 and CTLA-4 in Pancreatic Versus Non-Pancreatic Periampullary Adenocarcinoma: An Immunohistochemical Study

Programmed Cell Death Ligand 1(PD-L1) Expression in Molecular Subtypes of Breast Cancer

CD8&CD163 EXPRESSION IN TUMOR MICROENVIRONMENT OF RENAL CELL CARCINOMA AND THEIR RELATION TO PD-L1 EXPRESSION

Histopathological and Immunohistochemical Study of the Prognostic Significance of Cox2 and CDX2 Expression in the Available Cases of Colorectal Carcinoma

The impact of CD44 immunoreactivity on survival of patients with colorectal cancer

Evaluation of Histopathological and Prognostic Significance of Programmed Death Ligand 1 (PD-L1) Expression of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma